共查询到20条相似文献,搜索用时 78 毫秒
1.
目的:从专利信息角度入手对医学人工智能产业进行分析,以期实现该行业长久快速发展。方法:利用国家知识产权局专利数据库构建检索策略,对检索结果从专利态势、申请人实力和技术层面进行分析。结果:我国医学人工智能领域专利数量自2008年开始逐年上升,国内专利申请量主要集中在广东、北京和江苏等发达地区,申请人中来华企业属于技术领导者和潜在竞争者,我国申请人大部分属于技术活跃者。专利技术分布在A61B(诊断外科)、A61H(理疗装置)等小类,识别图形、图像分析以及数字计算和数据处理等是我国医学人工智能领域的研究热点。结论:我国在医学人工智能领域属于技术活跃者,但专利质量仍是阻碍领域发展的短板,产业化程度和研发效率相对较低也是亟待解决的问题。医学影像学的人工智能技术发展表现突出,是实现领域创新的难得机遇。 相似文献
2.
3.
4.
5.
6.
目的 探讨医学人工智能领域伦理治理的重点。方法 通过综合查阅相关文献,比较中外医学人工智能领域相关法律法规,分析潜在伦理问题的治理重点,并提出相应的治理策略。结果 目前中国医学人工智能领域相关法律法规和监管体系有待完善,伦理治理的重点应着眼于保护隐私权、保障算法的透明与公正、厘清责任界定和分配、明确公众认知和态度等核心问题。结论 政府和社会各界应积极借鉴国际立法经验,通过加强顶层设计、健全政策法规、重视公众反馈、强化跨学科合作,从政策制定、法律框架、科学研究和技术研发等方面构建一个全方位、多层次的伦理治理体系。 相似文献
7.
8.
9.
10.
11.
12.
李科威 《湖南中医药大学学报》2016,(8):80-81
大系统医学人工智能在中国的第一次兴起,是伴随着微型计算机引入中国,时间点在上世纪八十年代,技术特征是模仿诊疗过程,典型应用集中在中医界,杰出代表是朱文锋教授[1]。但发展至上世纪九十年代中后期,由于大系统医学人工智能是一门复杂的交叉学科,对人才的复合技能要求非常高,特别是数学建模技能对于一些医学科研工作来说很难,从而使得医学人工智能的发展较为缓慢,科凌力智能也不例外,但一直在坚持。今天,阿尔法围棋(AlphaGo)的面世,又激起了我们坚持下去的勇气。 相似文献
13.
Chinese Innovative Alliance of Industry Education Research Application of Artificial Intelligence for Medical 《中国医学科学杂志(英文版)》2019,34(2):89-89
In the afternoon of March 26,2019, The White Paper on Medical Imaging Artificial Intelligence in China was officially released in Beijing by the Chinese Innovative Alliance of Industry, Education, Research and Application of Artificial Intelligence for Medical Imaging (CAIERA). The white paper was co-operatively written by the medical imaging experts from the tertiary Chinese hospitals, the scientific experts from AI research institutions and the leading AI medical enterprises in China. The contents of the white paper not only cover the up-to-date application of AI in medical field, the latest advances of AI algorithms in medical image processing, the data requirement for medical AI development, and the current situation of structured data, but also expatiate the goal and challenge of clinical application for medical imaging AI development in 16 medical subject areas, which helps to identify the demands and opportunities for the AI industry. Forty representative enterprises of AI medical imaging in China were introduced in the white paper. The white paper points out the three key problems in development of AI products: the robustness, ease of usage and data security, which provides guidance of direction and strategy for the enterprises. Particularly, in view of the national policy on developing AI, the white paper gives a profound analysis on the challenges and the opportunities that medical imaging AI is facing. These contents agglomerate the cutting-edge efforts of experts in the industry-academia-research-application chain of medical AI, represent the mainstream voice of the society in China. The White Paper will play a guiding role in understanding the market demands and establishing standardized systems in the path of landing AI products in the field medical imaging. Full text of the White paper is publicly accessible from the CAIERA website, or by scanning the 2D code in the article. 相似文献
14.
目的:通过引用人工智能技术,解决电子病案管理系统中存在的缺陷。方法:采用文字识别、语音识别、生物识别、人脸识别等技术,对电子病案进行检索、整合、统计、分析。结果:通过人工智能技术在电子病案管理系统中的应用,大大提高了病案管理人员的工作效率,助力临床科研和教学。结论:人工智能技术的广泛应用,为医疗卫生信息化的发展带来质的飞跃,人们将不仅仅是借助信息化的力量提高工作效率,并且可以利用信息化的数据整合,为以后的发展发挥更大的作用。 相似文献
15.
医学人工智能作为一门新的科学技术,是人工智能的一个重要分支,其快速发展与应用带来了许多伦理问题。正确认识并积极处理医学人工智能带来的伦理问题,最大程度发挥其作用,为人类提供最佳水平的诊疗技术,避免给社会及人类造成不良影响,是目前迫切需要重视的问题。本文探讨了医学人工智能引发的伦理问题,并对医学人工智能的伦理发展进行了思考与分析。 相似文献
16.
从医学人工智能研究对象的特殊性入手,分析了经典决定论工具的成长局限和不适应原理,提出新的生态动力学理论结构和操作方法,并据此建立起新的医学人工智能模型。 相似文献
17.
Ovarian cancer is one of the three most common gynecological cancers in the world, and is regarded as a priority in terms of women's cancer. In the past few years, many researchers have attempted to develop and apply artificial intelligence (AI) techniques to multiple clinical scenarios of ovarian cancer, especially in the field of medical imaging. AI-assisted imaging studies have involved computer tomography (CT), ultrasonography (US), and magnetic resonance imaging (MRI). In this review, we perform a literature search on the published studies that using AI techniques in the medical care of ovarian cancer, and bring up the advances in terms of four clinical aspects, including medical diagnosis, pathological classification, targeted biopsy guidance, and prognosis prediction. Meanwhile, current status and existing issues of the researches on AI application in ovarian cancer are discussed. 相似文献
18.
19.
目的:分析医学人工智能临床试验注册现状,为医学人工智能临床转化研究提供参考和证据支持。方法:通过ClinicalTrials.gov注册平台对医学人工智能临床试验数据进行采集、分析,采用文献计量学及对比研究的方法,从注册数量、研究类型、分期、适应证和申办者等角度进行医学人工智能临床试验注册现状研究。结果与结论:全球医学人工智能临床试验共649项,中国50项,位列全球第二位,但与美国尚存在较大差距;全球医学人工智能随机对照试验295项,中国12项;国际多中心临床试验32项,中国大陆未见参与;全球医学人工智能临床试验处于Ⅱ期的数量最多;全球医学人工智能临床试验适应证主要集中于疾病监测或健康管理、医学影像辅助诊断、疾病预测和治疗等,中国主要集中于诸如眼病筛查、肿瘤诊断等医学影像辅助诊断;全球医学人工智能临床试验的申办者共422个,中国29个,注册数量前15位申办者中大多为研究机构和医疗机构。 相似文献
20.
In recent years, artificial intelligence (AI) has developed rapidly in the field of medical imaging. However, the collaborations among hospitals, research institutes and enterprises are insufficient at the present, and there are various issues in technological transformation and value landing of products in this area. To solve the core problems in the developmental path of medical imaging AI, the Chinese Innovative Alliance of Industry, Education, Research and Application of Artificial Intelligence for Medical Imaging compiled the White Paper on Medical Image AI in China. This article introduces the current status of collaboration, the clinical demands for medical imaging AI technique, and the key points in AI technology transformation: robustness, usability and security. We are facing challenges of lacking industry standards, data desensitization standard, assessment system, as well as corresponding regulations and policies to realize the application values of AI products in medical imaging. Further development of AI in medical imaging requires breakthroughs of the core algorithm, deep involvement of doctors, input from capitals, patience from societies, and most importantly, the resolutions from government for multiple difficulties in links of landing the technology. 相似文献